These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15176948)

  • 61. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica.
    McManus DP; Dalton JP
    Parasitology; 2006; 133 Suppl():S43-61. PubMed ID: 17274848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma.
    Yang J; Zhao J; Yang Y; Zhang L; Yang X; Zhu X; Ji M; Sun N; Su C
    Immunology; 2007 Jan; 120(1):8-18. PubMed ID: 17042799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prospects of vaccination against schistosomiasis].
    Capron A
    Bull Acad Natl Med; 1989 Apr; 173(4):495-502; discussion 502-4. PubMed ID: 2790533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection.
    Zhu Y; Si J; Harn DA; Xu M; Ren J; Yu C; Liang Y; Yin X; He W; Cao G
    Parasitology; 2006 Jan; 132(Pt 1):67-71. PubMed ID: 16393355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccination of goats with 31 kDa and 32 kDa Schistosoma japonicum antigens by DNA priming and protein boosting.
    Tang L; Zhou Z; Chen Y; Luo Y; Wang L; Chen L; Huang F; Zeng X; Yi X
    Cell Mol Immunol; 2007 Apr; 4(2):153-6. PubMed ID: 17571462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Mem Inst Oswaldo Cruz; 1995; 90(2):235-40. PubMed ID: 8531664
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunologic aspects of schistosomiasis.
    Capron A; Dessaint JP
    Annu Rev Med; 1992; 43():209-18. PubMed ID: 1580585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Construction of a novel Schistosoma japonicum DNA vaccine pBK-Sj14-3-3 and studies on its immunoprotection in mice].
    Li DF; Chen YS; Zu Y; Shen JL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):193-5. PubMed ID: 15182491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Heat shock proteins as vaccine candidates.
    Newport GR
    Semin Immunol; 1991 Jan; 3(1):17-24. PubMed ID: 1893121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host.
    Weinstock JV
    Immunol Invest; 1992 Aug; 21(5):455-75. PubMed ID: 1428020
    [No Abstract]   [Full Text] [Related]  

  • 74. The immunobiology of Th1 polarization in high-pathology schistosomiasis.
    Stadecker MJ; Asahi H; Finger E; Hernandez HJ; Rutitzky LI; Sun J
    Immunol Rev; 2004 Oct; 201():168-79. PubMed ID: 15361240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The protective efficacy against Schistosoma japonicum infection by immunization with DNA vaccine and levamisole as adjuvant in mice.
    Wang X; Jin H; Du X; Cai C; Yu Y; Zhao G; Su B; Huang S; Hu Y; Luo D; She R; Luo X; Zeng X; Yi X; Wang B
    Vaccine; 2008 Mar; 26(15):1832-45. PubMed ID: 18329762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Schistosomiasis vaccines: where do we stand?
    Tebeje BM; Harvie M; You H; Loukas A; McManus DP
    Parasit Vectors; 2016 Sep; 9(1):528. PubMed ID: 27716365
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon.
    Siddiqui AA; Pinkston JR; Quinlin ML; Saeed Q; White GL; Shearer MH; Kennedy RC
    Vaccine; 2005 Feb; 23(12):1451-6. PubMed ID: 15670880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Research progress on schistosome vaccine and prospect of its application in China].
    Wang SP; Chen XC; Gao DM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Oct; 27(5):402-11. PubMed ID: 20066972
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Schistosoma mansoni eggs excrete specific free oligosaccharides that are detectable in the urine of the human host.
    Robijn ML; Koeleman CA; Hokke CH; Deelder AM
    Mol Biochem Parasitol; 2007 Feb; 151(2):162-72. PubMed ID: 17188764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lysosome-associated membrane glycoprotein (LAMP)--preliminary study on a hidden antigen target for vaccination against schistosomiasis.
    Nawaratna SS; Gobert GN; Willis C; Mulvenna J; Hofmann A; McManus DP; Jones MK
    Sci Rep; 2015 Oct; 5():15069. PubMed ID: 26472258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.